Connection
David Simpson to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications David Simpson has written about Receptors, Tumor Necrosis Factor, Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.010 |
|
|
|
-
Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
Score: 0.010